Seller finished at 15c, page-79

Well I think with a good result for efficacy they will get formal approval and start commercial implants. There will be some delays (as always) because the first 100 patients will be part of another trial for the FDA, but they did go to pains to point out they COULD manage do 5 patients a week (at least on one occasion). So the potential is there for them to turn a profit relatively quickly once they get themselves organised. Looking at the price now I think once they are selling treatments, a share price of over 50c would be very likely.

The only restriction for them will be availability of staff and operating theatre time. They have plenty of NTcell, and a long queue of patients.